Skip Navigation
Search Menu
The Sidney Kimmel Comprehensive Cancer Center

Promise and Progress
Print This Page

Bloomberg~Kimmel Institute for Cancer Immunotherapy

This event has been recorded.

Watch @VP Joe Biden join @MikeBloomberg as they launch the newest institute at Johns Hopkins.

@HopkinsMedicine

Johns Hopkins is proud to announce the establishment of the new cancer immunotherapy institute embracing Vice President Joe Biden's cancer moonshot.

Michael R. Bloomberg, Johns Hopkins ChampionMichael R. Bloomberg,
Johns Hopkins Champion

Johns Hopkins has answered the call set forth by Vice President Biden’s “Moonshot Initiative” to cure cancer with the establishment of the new Bloomberg~Kimmel Institute for Cancer Immunotherapy. This institute, studying immunotherapy, has the potential to eventually end all forms of cancer.

Sidney Kimmel, Johns Hopkins ChampionSidney Kimmel,
Johns Hopkins Champion

At this critical time, when the Kimmel Cancer Center’s discoveries in immunotherapies are having unprecedented success, two Johns Hopkins champions have once more stepped up to the challenge and are providing essential funding to help ensure we realize the full potential of the immune system’s ability to fight cancer.

Sidney Kimmel who helped lay the foundation for the Sidney Kimmel Comprehensive Cancer Center and leading Johns Hopkins supporter, three-term mayor of New York and philanthropist, Michael R. Bloomberg are each contributing $50 million over the next five years towards the establishment of this unprecedented institute.

This support comes at a vital time. Laboratory and clinical research ensures that we will unravel the intertwined biology of the cancer cell, the immune cell and the cells that surround the tumor so that we can begin to harness the power of the immune system for all cancer patients. For decades, cancer experts have sought this moment-when the immune system could precisely and predictably be recruited to fight cancer universally across all cancer types. The success of immunotherapies is real, but the fill promise cannot be realized without continued research.

Vice President Joe Biden and Michael R. Bloomberg shake hands

Vice President Biden Speaks at Launch of Bloomberg~Kimmel Institute for Cancer Immunotherapy

Gifts of $125 million will hasten development of immunotherapy treatments with the potential to cure and end all forms of cancer.

Vice President Joe Biden believes cancer research will progress more in the next 10 years than it has in the past 50, thanks to treatments that unleash the immune system to detect and attack cancer cells.

Timeline of Immunotherapy Innovation at Johns Hopkins
Johns Hopkins Kimmel Cancer Immunotherapy TeamJohns Hopkins Kimmel Cancer Immunotherapy Team

Johns Hopkins Bloomberg~Kimmel Institute for Cancer Immunotherapy

Johns Hopkins announces a $125 million philanthropic investment that will establish the Bloomberg~Kimmel Institute for Cancer Immunotherapy. The Institute will focus on the development of promising therapies that unleash the power of patients’ natural defense—their immune system—to seek out and eradicate cancer.

Immunotherapy is a game changer. We need more research to take us the rest of the distance, but we don't think there is a single cancer that the patient's own immune system ultimately can't beat.

- Drew Pardoll, M.D., Ph.D., Director of the Bloomberg-Kimmel Cancer Institute

Throughout my career as a clinician and scientist and now as cancer center director, I cannot recall another time when so many opportunities were within our grasp.

- William Nelson, M.D., Ph.D., Director,
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

cancer cells (computer graphic)

What is Immunotherapy?

Immunotherapy is a method of harnessing the body’s own ability to fight cancer. The immune system -- the organs and cells that normally protect us from infections and disease – sometimes has a tough time fighting cancer.